China’s centralised medicine procurement programme launched in 2019 has helped to bring down prices of many drugs. Photo: Shutterstock China’s centralised medicine procurement programme launched in 2019 has helped to bring down prices of many drugs. Photo: Shutterstock
China’s centralised medicine procurement programme launched in 2019 has helped to bring down prices of many drugs. Photo: Shutterstock

First company banned from China’s centralised drugs procurement programme after it fails to honour contract

  • Authorities to tighten the criteria for pharmaceutical companies that want to take part in the centralised drugs procurement programme
  • North China Pharmaceutical is the first drug maker in the programme to renege on its contract

Topic |   Health in China
China’s centralised medicine procurement programme launched in 2019 has helped to bring down prices of many drugs. Photo: Shutterstock China’s centralised medicine procurement programme launched in 2019 has helped to bring down prices of many drugs. Photo: Shutterstock
China’s centralised medicine procurement programme launched in 2019 has helped to bring down prices of many drugs. Photo: Shutterstock
READ FULL ARTICLE